TY  - GEN
AU  - Tai,Cheng-Jeng
AU  - Huang,Ming-Te
AU  - Wu,Chih-Hsiung
AU  - Wang,Chien-Kai
AU  - Tai,Chen-Jei
AU  - Chang,Chun-Chao
AU  - Hsieh,Cheng-I
AU  - Chang,Yu-Jia
AU  - Wu,Chang-Jer
AU  - Kuo,Li-Jen
AU  - Wei,Po-Lei
AU  - Chen,Ray-Jade
AU  - Chiou,Hung-Yi
TI  - Combination of Two Targeted Medications (Bevacizumab Plus Cetuximab) Improve the Therapeutic Response of Pancreatic Carcinoma
SN  - 1536-5964
PY  - 2016///0912
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Bevacizumab
KW  - Cetuximab
KW  - Disease Progression
KW  - Disease-Free Survival
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Nausea
KW  - chemically induced
KW  - Pancreatic Neoplasms
KW  - drug therapy
KW  - Retrospective Studies
KW  - Vomiting
N1  - Publication Type: Clinical Trial, Phase II; Journal Article
UR  - https://doi.org/10.1097/MD.0000000000003259
ER  -